Taytulla Kit
Product Images NDC 0023-5862

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Taytulla (NDC 0023-5862). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

The Following Structural Formula For The Chemical Name Of Ethinyl Estradiol Is [19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17a)-]. The Empirical Formula Of Ethinyl Estradiol Is C20h24o2. (Taytulla 01)

The Following Structural Formula For The Chemical Name Of Ethinyl Estradiol Is [19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17a)-]. The Empirical Formula Of Ethinyl Estradiol Is C20h24o2. (Taytulla 01)
This appears to be a compilation of different studies conducted on the risk of breast cancer with the use of combined oral contraceptives. The studies cited include the NICHD Women's Care Study, French E3W coort Study, Shanghal Women's Health Study, The Nurses' Health Study, Oxford Family Planning Study, and the Danish Sex Hormone Register Study. The text also features effect estimates for different scenarios of combined oral contraceptive use.*
FDA Label Image

The Following Structural Formula For The Chemical Name Of Norethindrone Acetate Is [19-norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17a)-]. The Empirical Formula Of Norethindrone Acetate Is C22h28o3. (Taytulla 02)

The Following Structural Formula For The Chemical Name Of Norethindrone Acetate Is [19-norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17a)-]. The Empirical Formula Of Norethindrone Acetate Is C22h28o3. (Taytulla 02)
FDA Label Image

Figure 1. Mean Plasma Norethindrone Concentration-time Profiles Following Single- And Multiple-dose Oral Administration Of Norethindrone Acetate/ethinyl Estradiol Tablets To Healthy Female Volunteers Under Fasting Condition (n = 17) (Taytulla 03)

Figure 1. Mean Plasma Norethindrone Concentration-time Profiles Following Single- And Multiple-dose Oral Administration Of Norethindrone Acetate/ethinyl Estradiol Tablets To Healthy Female Volunteers Under Fasting Condition (n = 17) (Taytulla 03)
FDA Label Image

Figure 2. Mean Plasma Ethinyl Estradiol Concentration-time Profiles Following Single- And Multiple-dose Oral Administration Of Norethindrone Acetate/ethinyl Estradiol Tablets To Healthy Female Volunteers Under Fasting Condition (n = 17) (Taytulla 04)

Figure 2. Mean Plasma Ethinyl Estradiol Concentration-time Profiles Following Single- And Multiple-dose Oral Administration Of Norethindrone Acetate/ethinyl Estradiol Tablets To Healthy Female Volunteers Under Fasting Condition (n = 17) (Taytulla 04)
FDA Label Image

The Following Chart Shows The Chance Of Getting Pregnant For Women Who Use Different Methods Of Birth Control. Each Box On The Chart Contains A List Of Birth Control Methods That Are Similar In Effectiveness. The Most Effective Methods Are At The Top Of The Chart. The Box On The Bottom Of The Chart Shows The Chance Of Getting Pregnant For Women Who Do Not Use Birth Control And Are Trying To Get Pregnant. (Taytulla 05)

The Following Chart Shows The Chance Of Getting Pregnant For Women Who Use Different Methods Of Birth Control. Each Box On The Chart Contains A List Of Birth Control Methods That Are Similar In Effectiveness. The Most Effective Methods Are At The Top Of The Chart. The Box On The Bottom Of The Chart Shows The Chance Of Getting Pregnant For Women Who Do Not Use Birth Control And Are Trying To Get Pregnant. (Taytulla 05)
FDA Label Image

The Taytulla-pill Pack Has 24 "active" Pink Capsules (with Hormones) To Be Taken For 24 Days, Followed By 4 "reminder" Maroon Capsules (without Hormones) To Be Taken For The Next Four Days. (Taytulla 06)

The Taytulla-pill Pack Has 24 "active" Pink Capsules (with Hormones) To Be Taken For 24 Days, Followed By 4 "reminder" Maroon Capsules (without Hormones) To Be Taken For The Next Four Days. (Taytulla 06)
FDA Label Image

Principal Display Panelndc 0023-5362-30taytulla1 mg/ 20 Mcg28 Day Regimenrx Only (Taytulla 07)

Principal Display Panelndc 0023-5362-30taytulla1 mg/ 20 Mcg28 Day Regimenrx Only (Taytulla 07)
The text describes various forms of birth control methods and their success rates in preventing pregnancies. The methods listed include implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, spermicide, and withdrawal. The success rates are given in terms of pregnancies per 100 women, with the most effective methods having fewer than 1 pregnancy per 100 women. "Nosex during the most in one year fertile days of the monthly cycle" is also listed as a method of preventing pregnancies.*
FDA Label Image

Taytulla 08

Taytulla 08
This text appears to be a set of instructions for someone starting to take birth control pills. It gives guidance on how to use the pill pack based on the day the person's period starts. The pack includes a day label strip to help keep track of which pill to take each day. The text also includes a reminder to take the pills in order from left to right each week.*
FDA Label Image

Taytulla 09

Taytulla 09
Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.